Going Above and Beyond CoC Standard 4.4 - Genetics and Risk Assessment
Watch the webinar recording to get expert insight from Dr. William Dooley, Surgical Oncologist at the University of Oklahoma and Kelly Hall, VP of Commercial Strategy at CancerIQ, into standard 4.4 requirements and approaches to meeting the standard. In this webinar, we cover:
An overview of the new standard from Dr. William Dooley, Surgical Oncologist and Commission on Cancer Surveyor
What the new standard means for you and your center
The best practices for implementing standard 4.4 - genetics and risk assessment